Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2003-11-25
pubmed:abstractText
Blood groups B and P1 are substrates for the lysosomal enzyme alpha-galactosidase A. Therefore, patients with alpha-Gal A deficiency and blood groups B or P1 may exhibit more severe disease. In 48 Fabry patients distribution of blood group was not different from that in the Dutch population. No patient had blood group B. Clinical symptoms did not differ between bloodgroup P1 or P2 patients. We conclude that blood groups B and P1 are not overrepresented in Dutch Fabry patients. Blood group P1 is not correlated with more severe disease and cannot be considered a significant risk factor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1079-9796
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
324-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:articleTitle
Blood group does not correlate with disease severity in patients with Fabry disease (alpha-galactosidase A deficiency).
pubmed:affiliation
Department of Internal Medicine, Clinical Haematology, F4-224 Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. g.e.linthorst@amc.uva.nl
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't